1. Home
  2. SHLT vs RANI Comparison

SHLT vs RANI Comparison

Compare SHLT & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHLT
  • RANI
  • Stock Information
  • Founded
  • SHLT 1987
  • RANI 2012
  • Country
  • SHLT Israel
  • RANI United States
  • Employees
  • SHLT N/A
  • RANI 140
  • Industry
  • SHLT Business Services
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • SHLT Consumer Discretionary
  • RANI Health Care
  • Exchange
  • SHLT Nasdaq
  • RANI Nasdaq
  • Market Cap
  • SHLT 46.9M
  • RANI 55.3M
  • IPO Year
  • SHLT N/A
  • RANI 2021
  • Fundamental
  • Price
  • SHLT $2.34
  • RANI $1.66
  • Analyst Decision
  • SHLT Strong Buy
  • RANI Strong Buy
  • Analyst Count
  • SHLT 1
  • RANI 6
  • Target Price
  • SHLT $11.00
  • RANI $11.33
  • AVG Volume (30 Days)
  • SHLT 3.3K
  • RANI 2.3M
  • Earning Date
  • SHLT 09-26-2024
  • RANI 03-19-2025
  • Dividend Yield
  • SHLT N/A
  • RANI N/A
  • EPS Growth
  • SHLT N/A
  • RANI N/A
  • EPS
  • SHLT N/A
  • RANI N/A
  • Revenue
  • SHLT $55,939,000.00
  • RANI N/A
  • Revenue This Year
  • SHLT N/A
  • RANI N/A
  • Revenue Next Year
  • SHLT N/A
  • RANI N/A
  • P/E Ratio
  • SHLT N/A
  • RANI N/A
  • Revenue Growth
  • SHLT N/A
  • RANI N/A
  • 52 Week Low
  • SHLT $2.03
  • RANI $1.24
  • 52 Week High
  • SHLT $7.96
  • RANI $8.75
  • Technical
  • Relative Strength Index (RSI)
  • SHLT 37.15
  • RANI 54.80
  • Support Level
  • SHLT $2.24
  • RANI $1.59
  • Resistance Level
  • SHLT $2.40
  • RANI $1.90
  • Average True Range (ATR)
  • SHLT 0.14
  • RANI 0.15
  • MACD
  • SHLT -0.02
  • RANI 0.03
  • Stochastic Oscillator
  • SHLT 37.85
  • RANI 56.36

About SHLT SHL Telemedicine Ltd

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Share on Social Networks: